insights_auto
Why is SRPT down 2.48%?
Dive Deeperchevron_right
SRPT:NASDAQ
Sarepta Therapeutics Inc
$17.73
arrow_downward
-2.48%(-0.45) 1D
$17.73
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 23, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
$17.94
High
$18.12
Low
$17.16
Mkt. cap
1.87B
Avg. vol.
2.94M
Volume
1.29M
52-wk high
$24.68
52-wk low
$14.69
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
Open
$17.94
High
$18.12
Low
$17.16
Mkt. cap
1.87B
Avg. vol.
2.94M
Volume
1.29M
52-wk high
$24.68
52-wk low
$14.69
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
News stories
From web sources and news partners
Yahoo Finance
·
3 hours ago
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
Stocktwits
·
4 hours ago
Apollo’s Torsten Slok Warns AI Has Delivered ‘Zero Financial Payoff’ Outside Tech — 'AI Story Will Be Decided In The S&P 493, Not The Mag 7'
Cassandra Unchained | Michael Burry
·
19 hours ago
Foundations: The Fate of the S&P 500’s Worst Stocks, the Y2K Analogue, and Time for Small Caps?
Investor's Business Daily
·
1 hour ago
Futures Due; It's A Doom-And-Bloom Market
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc